Pipeline
Making Meaningful Strides in Healthcare
Direct Biologics is devoted to enhancing patient lives with a passionate commitment driving our every effort. Our industry experts ensure that our clinical trials are designed and carried out with the highest regard for the safety and wellbeing of patients. We deeply appreciate the thoughtful consideration that goes into deciding to participate in clinical research, and we are immensely grateful to the patients and families who make that choice.
Current Clinical Trials
Learn more about our current clinical trials here
Asset
Indication
Discovery / Preclinical
Phase 1
Phase 2
Phase 3
ExoFlo™(DB-2Q)
Acute Respiratory Distress Syndrome (ARDS)
DB-3Q
Perianal Fistulizing Crohn’s Disease
DB-3Q
Medically Refractory Crohn’s Disease
DB-3Y
Medically Refractory Ulcerative Colitis